Can-Fite BioPharma Ltd.CANFNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-55.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-55.8%/yr
vs -10.9%/yr prior
Acceleration
-44.9pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 0.79% |
| 2023 | 18.83% |
| 2022 | 21.38% |
| 2021 | 9.17% |
| 2020 | -17.76% |
| 2019 | -121.78% |
| 2018 | 26.60% |
| 2017 | 14.57% |
| 2016 | -34.59% |
| 2015 | 10.06% |